Abstract
Safety in contraception has two main aspects: the safety of the contraceptive efficacy and safety with respect to the health of the treated person. At present, neither aspect affects the male population, with the exception of those males who undergo vasectomy. One has to assume that the condom is a suitable contraceptive in many cases, but the risk of its being ineffective affects only the woman. In the future, when the new methods of male contraception are realized, males may be affected, but at the moment all health risks are borne by females. The safety of the contraceptive efficacy only concerns the health of the woman. An ineffective contraceptive treatment may cause an acute health risk if pregnancy is interrupted by an inappropriate method. The efficacy of contraceptive methods always has its social aspects. Fertility control in Europe differs from that in developing countries. Therefore, the risks of the efficacy can only be discussed when the social aspects are included. Another aspect can be the prevention of pregnancy of an ill or older woman. In such a case, again health risks are closely connected with the efficacy of the fertility control.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Liu, G. Z., Cao, J. and Ch’iu, K. (1984). Alleviation of side effects produced by gossypol used as male contraception. In Seventh International Congress of Endocrinology, July 1–7, Quebec. (Amsterdam: Excerpta Medica) (In press )
Liu, Z. Q., Liu, G. Z., Hei, L. S., Zhang, R. A. and Yu, C. Z. (1981). Clinical trial of gossypol as a male antifertility agent. In Fen, C. C., Griffin, D. and Woolman, A. (eds.) Recent Advances in Fertility Regulation, pp. 160–163. ( Geneva: ATAR )
Liu, G. Z., Lyle, K. and Jian, C. (1984). Clinical trial of gossypol. In Future Aspects in Contraception. International Symposium, September 5–8, Heidelberg. ( In press )
von Eickstedt, K.-W. (1984). LHRH agonists and antagonists. Aspects of their safety and efficacy. In International Symposium on LHRH and its Analogues, June 28–30, Quebec. (Amsterdam: Elsevier) (In press )
Pike, M. C., Henderson, B. E., Krailo, M. D., Duke, A. and Roy, S. (1983). Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet, ii, 926
Hormondosierung in oralen Kontrazeptiva. Eine Stellungnahme des Bundesgesundheitsamtes. Dtsches Ärzbl., 80, 23
Rochefort, H. (1983). Role des hormones stéroides sexuelles dans la concérogenèse mammaire humaine. In Renaud, R. and Garirard, B. (eds.) Contraception et Sein, pp. 106–119. ( Paris: Masson )
Hearn, J. P. (1981). Laboratory primates for the development of new methods of fertility control. In Fen, C. C., Griffin, D. and Woolman, A. (eds.) Recent Advances in Fertility Regulation, pp. 164–176 ( Geneva: ATAR )
Nieschlag, E., Akhtar, F. B., Weinbauer, G. F., Schürmeyer, T. and Michel, E. (1984). LHRH analogues for male fertility control: Experiments in monkeys and men. In International Symposium on LHRH and its Analogues, June 28–30, Quebec. (Amsterdam: Elsevier) (In press )
Beck, L. R. and Pope, V. Z. (1984). Controlled-release delivery systems for hormones. A review of their properties and current therapeutic use. Drugs, 27, 528
Nuwayser, D. S., Williams, D. L., Kerrigan, J. H., Nucefora, W. A. and Armstrong, J. C. (1984). Microencapsulation of contraceptive steroids. In Zatuchni, G. I. et al. (eds.) Long-acting Contraceptive Delivery Systems, pp. 64–76. ( Philadelphia: Harper and Row )
Lewis, D. H. and Tice, T. R. (1984). Polymeric considerations in the design of microencapsulation of contraceptive steroids. In Zatuchni, G.I. et al. (eds.) Long-acting Contraceptive Delivery Systems, pp. 77–95. ( Philadelphia: Harper and Row )
Briggs, M. H. (1982). Stoffwechselveränderungen unter oralen hormonalen Kontrazeptiva. In Hammerstein, J. (ed.) Aktuelle Aspekte der hormonalen Kontrazeption, pp. 77–94. ( Amsterdam: Excerpta Medica )
Briggs, M. H. and Briggs, M. (1981). Metabolic effects of hormonal contraceptives. In Fen, C. C., Griffin, D. and Woolman, A. (eds.) Recent Advances in Fertility Regulation, pp. 83–111. ( Geneva: ATAR )
Stadel, B. V. (1981). Oral contraceptives and cardiovascular disease. Part I, N. Engl. J. Med, 305, 612, Part I I, 305, 672
Editor information
Rights and permissions
Copyright information
© 1985 MTP Press Limited
About this chapter
Cite this chapter
Von Eickstedt, KW. (1985). Preclinical and clinical aspects of safety in contraception. In: Runnebaum, B., Rabe, T., Kiesel, L. (eds) Future Aspects in Contraception. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4916-4_29
Download citation
DOI: https://doi.org/10.1007/978-94-009-4916-4_29
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8678-3
Online ISBN: 978-94-009-4916-4
eBook Packages: Springer Book Archive